NIH-funded research R01 grant

Investigating the long-term effects of azithromycin on childhood obesity and neurodevelopment after cesarean delivery

Official title: Childhood follow-up study of obesity and neurodevelopment after perinatal exposure to adjunctive azithromycin prophylaxis for cesarean delivery

Funded at University of Alabama at Birmingham · NIH-11070334 · Data updated 2026-11-12

This study is looking at how giving the antibiotic azithromycin to mothers during childbirth affects their children's growth and brain development, especially for those born by cesarean section, and it compares these kids to others who didn't get the antibiotic to see if there are any long-term effects.

More Obesity research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Alabama at Birmingham
NIH-funded
Lab location1 site (Birmingham, United States)
Project startJuly 20, 2020
Project endMarch 31, 2026
Funding year2025
Award (this year)$636,937
NIH project number5R01HD102962-05
Project IDNIH-11070334 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children aged 0 to 11 years who were born via cesarean delivery and were exposed to azithromycin or placebo during the perinatal period.

Less likely to help

Patients who were not born via cesarean delivery or did not receive azithromycin during the perinatal period are unlikely to benefit from this research.

What this research studies

This research examines how exposure to azithromycin during the perinatal period affects childhood obesity and neurodevelopment in children born via cesarean delivery. It compares outcomes in children who were exposed to azithromycin with those who received a placebo, focusing on growth patterns and cognitive development. The study involves a large cohort of children and aims to provide insights into the long-term implications of antibiotic use during delivery. By following up with these children over several years, the research seeks to understand any potential adverse effects linked to azithromycin exposure.

Why it matters

Potential benefit: If successful, this research could lead to improved guidelines for antibiotic use during cesarean deliveries, ultimately enhancing child health outcomes.

How similar studies have gone: Previous studies have shown significant benefits from azithromycin in reducing maternal infections, but this research is novel in its focus on long-term childhood outcomes.

Where this research is happening

  • University of Alabama at Birmingham
    Birmingham, United States
    Active

Researchers

  • Principal investigator: Subramaniam, Akila — University of Alabama at Birmingham
  • Study coordinator: Subramaniam, Akila

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.